Skip to main content

Table 2 Characteristics of Year 1 high utilizer (HU) groups

From: Characterization of high healthcare utilizer groups using administrative data from an electronic medical record database

 

Total (N = 388,162)

Non-HU (N = 322,905)

Cost (N = 14,647)

LOS (N = 217)

SOC (N = 26,179)

LOS-SOC (N = 44)

Cost-LOS (N = 6008)

Cost-SOC (N = 12,892)

Cost-LOS-SOC (N = 5270)

Age at first visit

38 (27–53)

36 (27–50)

55 (44–67)

55 (33–76)

36 (28–53)

32 (27–42)

66 (51–77)

51 (37–63)

58 (47–69)

PPSa, median (IQR)

3 (1–6)

2 (0–4)

15 (10–22)

9 (6–13)

7 (3–11)

6 (4–8)

25 (17–40)

14 (9–20)

29 (20–41)

N = 354,569

N = 292,096

N = 14,622

 

N = 23,469

  

N = 12,843

 

CCMIb, median (IQR)

0 (0–0)

0 (0–0)

1 (0–2)

0 (0–1)

0 (0–0)

0 (0–0)

2 (1–4)

1 (0–2)

2 (1–5)

Gender

 Female

162,057 (41.7%)

130,395 (40.4%)

4615 (31.5%)

132 (60.8%)

16,404 (62.7%)

20 (45.5%)

2415 (40.2%)

6104 (47.3%)

1972 (37.4%)

 Male

226,105 (58.3%)

192,510 (59.6%)

10,032 (68.5%)

85 (39.2%)

9775 (37.3%)

24 (54.5%)

3593 (59.8%)

6788 (52.7%)

3298 (62.6%)

Race

 Chinese

226,849 (58.4%)

187,417 (58.0%)

8548 (58.4%)

158 (72.8%)

15,376 (58.7%)

29 (65.9%)

3750 (62.4%)

8110 (62.9%)

3461 (65.7%)

 Indian

50,475 (13.0%)

42,748 (13.2%)

1482 (10.1%)

21 (9.7%)

4131 (15.8%)

4 (9.1%)

513 (8.5%)

1172 (9.1%)

404 (7.7%)

 Malay

45,709 (11.8%)

38,062 (11.8%)

1926 (13.1%)

15 (6.9%)

2806 (10.7%)

5 (11.4%)

933 (15.5%)

1270 (9.9%)

692 (13.1%)

 Others

65,129 (16.8%)

54,678 (16.9%)

2691 (18.4%)

23 (10.6%)

3866 (14.8%)

6 (13.6%)

812 (13.5%)

2340 (18.2%)

713 (13.5%)

Treatment type

 Subsidised only

263,111 (67.8%)

231,507 (71.7%)

8180 (55.8%)

167 (77.0%)

10,754 (41.1%)

23 (52.3%)

4403 (73.3%)

4987 (38.7%)

3090 (58.6%)

 Unsubsidised only

53,331 (13.7%)

37,901 (11.7%)

2885 (19.7%)

1 (0.5%)

8110 (31.0%)

2 (4.5%)

439 (7.3%)

3598 (27.9%)

395 (7.5%)

 Both subsidised and unsubsidised

71,720 (18.5%)

53,497 (16.6%)

3582 (24.5%)

49 (22.6%)

7315 (27.9%)

19 (43.2%)

1166 (19.4%)

4307 (33.4%)

1785 (33.9%)

Housing type

 1/2-room flats

10,106 (2.6%)

8087 (2.5%)

577 (3.9%)

7 (3.2%)

550 (2.1%)

0 (0%)

375 (6.2%)

289 (2.2%)

221 (4.2%)

 3-room flats and larger

245,741 (63.3%)

202,252 (62.6%)

9093 (62.1%)

163 (75.1%)

18,680 (71.4%)

32 (72.7%)

3956 (65.8%)

7872 (61.1%)

3693 (70.1%)

 Private

45,714 (11.8%)

37,736 (11.7%)

1414 (9.7%)

14 (6.5%)

3838 (14.7%)

3 (6.8%)

427 (7.1%)

1857 (14.4%)

425 (8.1%)

 Unknown

86,601 (22.3%)

74,830 (23.2%)

3563 (24.3%)

33 (15.2%)

3111 (11.9%)

9 (20.5%)

1250 (20.8%)

2874 (22.3%)

931 (17.7%)

 Death

8722 (47.5%)

4625 (1.4%)

1460 (10.0%)

20 (9.2%)

90 (0.3%)

0 (0%)

1626 (27.1%)

247 (1.9%)

654 (12.4%)

 Persistence of HU

16,052 (4.1%)

7108 (2.2%)

774 (5.3%)

19 (8.8%)

3819 (14.6%)

11 (25.0%)

651 (10.8%)

3244 (25.2%)

1863 (35.4%)

  1. aPPS Polypharmacy score, bCCMI Charlson Comorbidity Index score